Claraphi Advisory Network’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-852
| Closed | -$595K | – | 303 |
|
2022
Q1 | $595K | Sell |
852
-258
| -23% | -$180K | 0.17% | 127 |
|
2021
Q4 | $701K | Sell |
1,110
-122
| -10% | -$77K | 0.24% | 99 |
|
2021
Q3 | $745K | Sell |
1,232
-1,169
| -49% | -$707K | 0.26% | 86 |
|
2021
Q2 | $1.34M | Buy |
2,401
+31
| +1% | +$17.3K | 0.4% | 41 |
|
2021
Q1 | $1.12M | Buy |
+2,370
| New | +$1.12M | 0.31% | 68 |
|
2020
Q2 | – | Sell |
-924
| Closed | -$451K | – | 997 |
|
2020
Q1 | $451K | Buy |
+924
| New | +$451K | 0.21% | 92 |
|